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Snmmm'y--Treatment of rat liver cytosol containing temperature-transformed [3H]dexamethasone-bound 
receptors at 0°C with the sulfhydryl modifying reagent methyl methanethiosulfonate (MMTS) inhibits 
the DNA-binding activity Of the receptor, and DNA-binding activity is restored after addition of 
dithiothreitol (DTT). However, transformed receptors that are treated with MMTS and then separated 
from low M, components of cytosol by passage through a column of Scphadex G-50 have very little 
DNA-binding activity when DTT is added to regenerate sulfhydryl moities. The receptors will bind to 
DNA if whole liver cytosol or boiled liver cytosol is added in addition to DTI'. The effect of boiled 
cytosol is mimicked by purified rat thioredoxin or bovine RNase A in a manner that does not reflect 
the reducing activity of the former or the catalytic activity of the latter. This suggests that the reported 
ability of each of these heat-stable peptides to stimulate DNA binding by giucocorticoid receptors is 
not a biologically relevant action. We suggest that stimulation of DNA binding of partially purified 
receptors by boiled cytosol does not constitute a reconstitution of a complete cytosolic system in which 
the dissociated receptor must associate with a specific heat-stable accessory protein required for DNA 
binding, as has been suggested in the "two-step" model of receptor transformation recently proposed 
by Schmidt et al. (Schmidt T. J., Miller-Diener, A., Webb M. L. and Litwack G. (1985) J. biol. Chem. 
260, 16255-16262). 
INTRODUCTION 
Sulfhydryl groups are important for permitting 
several actions of steroid receptors. For example, 
SH-groups are required for glucocorticoid receptors 
in cytosol preparations to bind steroid [1], and sub- 
sequently, for transformed§ glucocorticoid-receptor 
complexes to bind to DNA [2]. Bodwell et a/.[3] have 
provided good evidence that the sulfhydryl groups 
required for DNA binding by the transformed 
receptor are different from those required for 
steroid binding. In addition, there is evidence that 
sulfur moieties must be in a reduced form for 
progesterone [4], androgen [5] and glucocorticoid¶ [6] 
:[:To whom correspondence should be addressed. 
§It should be noted that we will use the term "trans- 
formation" to describe the process whereby the steroid- 
bound receptor is converted to a form that binds t o  
nuclei, DNA-cellulose, etc. We have used the term 
"activation" to describe the process whereby the oxi- 
dized receptor is converted from a nonbinding form to 
a form that binds steroids. 
¶W. Tienrungroj, S. Meshinchi, E. R. Sanchez, S. E. Pratt, 
J. F. Grippo, A. Holmgren and W. B. Pratt, Manuscript 
submitted for publication. 
Abbreviations: MMTS, methyl methanethiosulfonate; 
Hepes, 4-(2-hydroxyethyl)-l-piperazine ethanesulfonic 
acid; DTT, dithiothreitol. 
receptors to undergo transformation. Our laboratory 
has been interested in defining the endogenous heat- 
stable cytosolic factors that are responsible for con- 
verting glucocorticoid receptors from a non-steroid- 
binding to a steroid-binding form [7, 8]. We have 
published evidence that glucocorticoid receptors in 
rat liver cytosol are maintained in a reduced, steroid- 
binding state by a NADPH-dependent, thioredoxin- 
mediated thiol-disulfide interchange system[9, 10]. 
Recently, in pursuing studies on receptor 
transformation to the DNA-binding state, we have 
considered a second possible interaction of 
thioredoxin with the glucocorticoid receptor[l 1]. 
We began by asking whether an enzyme was involved 
in temperature-mediated transformation of the 
glucocorticoid-receptor complex. Rat liver cytosol 
containing untransformed steroid-bound receptor 
was passed through a column of Bio-Gel ASM (in 
molybdate-free buffer) to separate the receptor from 
smaller cytosolic components that might be required 
for transformation. The fractions containing the 
steroid-receptor complex were combined and rapidly 
concentrated back to the original sample volume by 
filtration on an Amicon filter. The steroid-receptor 
complex in this Bio-Gel peak had little DNA binding 
activity, and in contrast to untreated cytosol, when 
the peak material was heated at 25°C, there was little 
or no increase in DNA binding [11]. 
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As the Bio-Gel-separated complex did not show 
increased binding when it was heated, it seemed 
possible that it had been separated from a smaller 
cytosolic component (or components) required for 
subsequent temperature-mediated transformation. 
Accordingly, we added either whole cytosol (contain- 
ing inactivated receptors) or boiled cytosol to the 
Bio-Gel-separated glucocorticoid-receptor complex 
and found that both cytosol preparations permitted 
increased binding of receptors to DNA-cellulose [1 l]. 
Not only was the boiled cytosol effective at increasing 
the DNA binding, but it was effective at 0°C. These 
observations suggested that a heat-stable component 
of cytosol was promoting DNA binding in a non- 
enzymatic manner. The activity in boiled cytosol 
behaved like thioredoxin in that it was smaller than 
the excluded material on Sephadex G-50 chro- 
matography (M, < 30,000), but most of it did not 
pass through an Amicon YM10 filter (Mr > 10,000). 
Therefore, we added purified rat liver thioredoxin to 
the Bio-Gel-separated receptors and found that it was 
as active as boiled cytosol in promoting DNA 
binding [l 1]. 
Taken together, these observations led us to specu- 
late that thioredoxin might be involved in the binding 
of transformed receptor to DNA [1 I]. Thioredoxin 
could act either by reducing the sulfur moieties re- 
quired for DNA binding, or possibly by binding to 
the receptor itself and producing a conformational 
change leading to an increased affinity for DNA. 
Thioredoxin is known, for example, to bind tightly to 
bacteriophage T7 DNA polymerase and through a 
conformational rather than a reductive action it 
permits the enzyme to function on double-stranded 
nucleic acids [12, 13]. Huber et al.[13] have speculated 
that thioredoxin binds to the enzyme near the binding 
crevice for double-stranded DNA and locks the 
duplex DNA into position. In this paper, we examine 
the effects of thioredoxin in promoting DNA binding 
by transformed glucocorticoid receptors whose DNA 
binding activity has been reversibly inactivated with 
a sulfhydryl modifying agent. We find that neither the 
effect of thioredoxin nor the similar effect produced 
by RNase in this system reflects a biologically rele- 
vant action of these heat-stable peptides. 
EXPERIMENTAL 
Materials 
[6,7-3H]Dexamethasone (45.8Ci/mmol) was ob- 
tained from New England Nuclear, Boston, MA. 
Insulin isolated from bovine pancreas, dithiothreitol, 
nonradioactive dexamethasone, methyl methane- 
thiosulfonate, ribonuclease A (EC 3.1.27.5) from 
bovine pancreas (Type XII-A), ribonuclease S- 
protein from bovine pancreas (Grade XII-PE) 
were obtained from J. T. Baker Chemical Co., 
Phillipsburg, New Jersey. 
Cell source and fractionation 
Liver was obtained from 100-200g male 
Sprague-Dawley rats which had bee~ adrenalecto- 
mized and maintained on 9% saline for 1 day, prior 
to sacrifice. Livers were removed immediately upon 
death, placed in ice-cold Earle's balanced salt solu- 
tion, and homogenized in a Waring blender in 1.5 vol 
of 10mM Hepes buffer, pH 7.35, per gram of wet 
weight, followed by Dounee homogenization. The 
tissue homogenate was centrifuged for 20 min at 
27,000g and the resulting supernatant was centri- 
fuged at 100,000g for 2 h. The 100,000g supernatant 
(referred to as cytosol) was used as the source of 
receptor, and was stored at -70°C  until used. 
Incubation conditions and steroid binding assay 
Incubations containing cytosol and other additions 
were prepared as noted in the figure and table 
legends. Most additions were made from stock solu- 
tions concentrated at least 10-fold. The cytosol was 
preincubated at 0°C with 50 mM [3H]dexamethasone, 
with or without a 1000-fold excess of nonradioactive 
dexamethasone, for at least 3 b to form bound recep- 
tor and was then subjected to the various experi- 
mental conditions. The steroid-receptor complexes 
were first transformed to the DNA-binding state by 
incubating the cytosol for 45 min at 25°C. Cytosol 
containing transformed [3H]dexamethasone-receptor 
complexes was then incubated for 1 h on ice with 
3 or 3.5mM MMTS to inactivate DNA-binding 
capacity. To reverse the MMTS inhibition of DNA 
binding in whole cytosol, DTT (20 mM) was added 
to the indicated samples and steroid binding and 
DNA binding were assayed. 
Transformed steroid-receptor complexes that had 
been treated with MMTS in whole cytosol were 
separated from free MMTS and small M,(<  30,000) 
components of cytosol by passage through a column 
(2.5 x 83 cm) of Sephadex G-50, eluting with 10 mM 
Hepes buffer, pH 7.35. The column eluate was moni- 
tored at 280 nm, and the fractions containing the 
macromolecular material (void volume peak) were 
pooled and concentrated to original volume by 
filtration on an Amicon YM10 filter which excludes 
molecules of Mr greater than approx 10,000. This 
preparation was then incubated on ice for 1 hour with 
DTT and other additions (as indicated in the figure 
and table legends) to permit reactivation of DNA- 
binding capacity prior to assay of steroid binding and 
binding to DNA-cellulose. 
Assay of  steroid binding and binding to DNA-cellulose 
Steroid binding was assayed by the charcoal ab- 
sorption method. Aliquots of each incubation mix- 
ture (0.1 ml), preincubated with steroid as described 
above, were incubated with 0.15 ml of a suspension 
of dextran-coated charcoal (1% charcoal (w/v) and 
0.2% dextran (w/v) in 10mM Hepes, pH 7.35, at 
4°C) for 10min at 0°C. After centrifugation at 
12,000g for 4min, 0.1 ml of the supernatant was 
assayed for radioactivity in 5 ml of scintillation fluid. 
The specific binding represents the average of dupli- 
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cate assays made in the absence of competing dex- 
amethasone minus the nonspecific binding value and 
is expressed in cpm/0.2 ml of original undiluted cyto- 
sol. In samples of MMTS-treated cytosol that were 
passed through Sephadex G-50, all of the bound 
steroid recovered in the macromolecular peak was 
considered to represent steroid-receptor complex. 
The assumption is valid, as a control experiment in 
which a nonspecifically bound sample was passed 
through the column revealed no binding in the 
macromolecular peak. 
To assay DNA binding, duplicate 0.1 ml aliquots 
of incubation mix were incubated for 45 rain with 
0.1 ml of a suspension of DNA-cellulose under 
constant stirring in an ice bath. The DNA-cellulose- 
bound material was washed and assayed for radio- 
activity as described previously [8]. DNA-cellulose 
was used as a 12.5%(v/v) suspension of DNA- 
cellulose (0.36 mg of native DNA/ml of  cellulose). 
Preparation of the endogenous activating factor 
The endogenous receptor activating factor (par- 
tially purified thioredoxin), which is called EAF in 
the legends to the tables and figures, was prepared 
from the 27,000g supernatant of rat liver essentially 
as previously described[9]. Briefly, the 27,000g 
supernatant fraction from rat liver was placed into 
a boiling water bath for 2 min and the denatured 
protein was removed by centrifuging at 27,000 g for 
5 min. One hundred ml of  the boiled supernatant 
were lyophilized to dryness, redissolved in 10 ml of 
0.1 mM Hepes buffer, pH 7.35, and desalted on a 
Sephadex G-50 column (2.5 x 67cm). All of the 
fractions obtained prior to the salt peak were pooled, 
lyophilized, dissolved in 4 ml of 0.1 mM Hepes buffer, 
pH 7.35, and incubated with 10 mM DTT for 30 min 
at 20°C to reduce all thioredoxin in the preparation. 
This material was applied to another Sephadex G-50 
column (2.5 x 80 cm) and eluted with 0.1 mM Hepes 
buffer, pH 7.35. The eluent was monitored at 280 nm 
and aliquots from every other fraction were assayed 
for thioredoxin activity by the insulin disulfide reduc- 
tion method described below. The thioredoxin- 
containing fractions, which are eluted in the same 
fractions as the endogenous receptor activating 
activity [9], were pooled, lyophilized to dryness and 
stored at -20°C until used. 
Thioredoxin assay 
Thioredoxin was assayed by the insulin disulfide 
reduction method of Holmgren[14]. An aliquot of 
each test sample was incubated in a final volume of 
0.6 ml in a I ml cuvette at room temperature with 
500/~1 of  bovine insulin (1 mg/ml), 8#1 of 50raM 
dithiothreitol, and the appropriate volume of 
100 mM phosphate buffer, pH 7.0, containing 2-raM 
*W. Tienrungroj, S. Mesh~nchi, E. R. Sanchez, S. E. Pratt, 
J. F. Grippo, A. Holmgren and W. B. Pratt, Manuscript 
submitted for publication. 
EDTA. Measurements were performed at A650 every 
5-10 rain. Rates of insulin reduction were expressed 
as the change in turbidity with time observed within 
a linear range between 0.2 and 1.0 A~so. The non- 
enzymatic reduction of insulin by dithiothreitol was 
recorded in a control cuvette without thioredoxin and 
this value (0.008-0.01 A650m x w.in -m) was subtracted 
from that recorded with each test sample to 
yield the rate of insulin reduction due to thioredoxin. 
A standard curve generated from purified rat liver 
thioredoxin was used to determine the thioredoxin 
concentration of the EAF preparation. 
Purified thioredoxin and thioredoxin antiserum 
Rat liver thioredoxin was purified to 80% of 
homogeneity at the Karolinska laboratory by the 
method of Holmgren and Luthman[ 15]. The purified 
thioredoxin (45/~m) was sent to the United States in 
the oxidized form in 50 mM Tris-HCl buffer, pH 7.5, 
8 mM EDTA. Antiserum against purified rat liver 
thioredoxin was prepared in rabbits as described 
previously [10]. The gamma-globulin fraction of  pre- 
immune and antithioredoxin serum was prepared as 
described [10], precipitated to 90% of saturation with 
solid ammonium sulfate and the suspensions sent by 
airmail from Stockholm to Ann Arbor. On arrival, 
the precipitate was collected by centrifugation, dis- 
solved in 10 mM Hepes buffer, p 7.35, and dialyzed 
against Hepes buffer overnight. After dialysis, the 
sera were returned to original volume with buffer and 
stored in 0.2 ml aliquots at -20°C until used. 
RESULTS 
Reversal of MMTS inhibition of DNA binding 
Methyl methanethiosulfonate (MMTS) reacts 
specifically with protein thiols to derivatize them by 
adding a thiomethyl group through the formation of 
a mixed disulfide. Bodwell et aL[2] have shown that 
0.25 mM MMTS is required to produce half-maximal 
inhibition of DNA binding by transformed glu- 
cocorticoid receptors in rat thymocyte cytosol. 
Tienrungroj eta/.* have found that a 10-fold higher 
concentration of MMTS is required to inhibit DNA 
binding by transformed receptors in rat liver cytosol, 
which has a higher concentration of giutathione 
available to react with the reagent [9]. The inhibition 
of DNA binding caused by 3 mM MMTS in whole 
rat liver cytosol is shown at the top of Table 1. At this 
concentration of MMTS, the steroid-receptor com- 
plex is not disrupted but DNA binding is inhibited 
and the inhibition can be reversed by adding 10 mM 
dithiothreitol (DTT) to the cytosol. 
After derivatization with MMTS, sylfyhdryl 
groups can be regenerated by reagents, like DTT, 
which promote thiol-disulfide interchange. If  regen- 
eration of receptor sulfhydryl groups is the only thing 
that is required to permit the MMTS-treated, trans- 
formed receptor to bind to DNA, then MMTS-treated 
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Table I. Small, heat-stable components of cytosol are required in addition to DTT to reverse MMTS 
inhibition of DNA binding 
% of total 
Specific Binding to complexes bound 
Condition Expt binding DNA-cellulose to DNA-eellulose 
cpm/0.2 ml 
Transformed cytosol alone 1 29,600 8760 30 
2 20,400 9270 45 
plus MMTS 1 33,100 4960 15 
2 17,700 4400 25 
plus MMTS then DTT I 32,200 8120 25 
2 20,100 7940 40 
MMTS-treated cytosol filtered 
through Sephadex G-50 
no additions 1 20,000 1240 6 
2 10,100 866 9 
plus DTT 1 21,700 2270 10 
2 11,900 1850 16 
plus whole cytosol 1 20,800 2500 12 
plus whole cytosol and DTT 1 21,800 4590 21 
plus boiled cytosol 1 21,100 2220 11 
2 12,000 2530 21 
plus boiled cytosol and DTT 1 20,400 4250 21 
2 11,600 4360 38 
Rat liver cytosol containing [3H]dexamethasone-bound, temperature-transformed receptors was incu- 
bated for 1 h on ice with 3 mM MMTS to reduce the DNA-binding activity of the receptor. A 
portion of MMTS-treated cytosol was then maintained at 0°C while the remainder was filtered 
through a column of Sephadex G-50 to separate the steroid-receptor complex from unreacted 
MMTS and from small components of cytosol. The fractions containing the material in the 
Sephadex void volume peak were concentrated back to original volume by Amicon filtration. 
Additions of whole rat liver cytosol or boiled rat liver cytosol (each at 40*/, of final incubation 
volume) or DTT (10mM) were made as indicated and both steroid binding and binding to 
DNA-cellulose were assayed 1 h later. Receptors in whole cytosol were inactivated by incubation 
at 37°C prior to addition. MMTS treated cytosol that was not filtered through Sephadex G-50 was 
maintained at 0°C and DTT was added to restore DNA-binding activity 5 h later, which is the time 
required for the rest of the material to be run through the Sepbadex and Amicon procedures. The 
results of two experiments are presented. The DNA-binding capacity of the untransformed, 0°C 
control cytosol was 1820 epm/0.2 ml in experiment 1 and 900 cpm/0.2 ml in experiment 2. 
receptors that have been separated from unreacted 
MMTS and small M, components of cytosol should 
be returned to the DNA binding state by exposing 
them to DTT alone. In the experiments shown in 
Table 1, temperature-transformed receptors were 
treated with MMTS and the cytosol was then filtered 
through a column of Sephadex G-50 to separate 
M M T S - t r e a t e d  r e c e p t o r  f r o m  a n y  u n r e a c t e d  M M T S  
a n d  s m a l l  M ,  c y t o s o i  c o m p o n e n t s  ( <  30 ,000) .  T h i s  
p r o c e d u r e  t a k e s  s e v e r a l  h o u r s  a n d  i s  a c c o m p a n i e d  b y  
a l o s s  o f  2 0 - 5 0 %  o f  t h e  s t e r o i d  b i n d i n g .  T r a n s f o r m e d  
r e c e p t o r s  t r e a t e d  i n  t h i s  m a n n e r  h a v e  a v e r y  l o w  
D N A  b i n d i n g  a c t i v i t y  t h a t  is  o n l y  p a r t i a l l y  r e s t o r e d  
b y  D T T .  R e a d d i t i o n  o f  c y t o s o l  c o m p o n e n t s  in  t h e  
Table 2. Reversal of MMTS inhibition of DNA binding by DTT and the endogenous receptor 
activating factor or purified thioredoxin 
% of total 
Specific Binding to complexes bound to 
Condition binding DNA-cellulose DNA-cellulose 
cpm/0.2 ml 
Transformed cytosol alone 31,400 12,800 41 
plus MMTS 40,500 6430 16 
plus MMTS then DTT 44,200 14,000 32 
MMTS-treated cytosol filtered 
through Sephadex G-50 
plus buffer alone 29,600 1610 5 
plus DTT 29,600 2490 8 
plus boiled cytosol 32,900 7760 24 
plus boiled cytosol and DTT 31,600 10,200 32 
plus EAF 32,300 6890 21 
plus EAF and DTT 30,900 10,500 34 
plus thioredoxin 31,300 3960 13 
plus thioredoxin and DTT 29,000 10,100 35 
Rat liver cytosol containing [3H]dexametbasone-bound, temperature-transformed receptors was 
incubated for l h on ice with 3.5 mM MMTS and filtered through Sephadex G-50 as 
described in the Legend to Table 1. Additions of boiled rat liver cytosol (at 40% of final 
incubation volume), endogenous activating factor (EAF, 40% by volume), or purified 
thioredoxin (4.5pmol), or each of these preincubated for 1 h at room temperature with 
20 mM DTT were made as indicated, and the mixtures were incubated on ice for 1 h prior 
to assay of steroid binding and binding to DNA-cellulose. The concentration of DTF in the 
incubation with the receptor was 10mM. MMTS-treated cytosol that was not filtered 
through Sephadex was reactivated by addition of DTT after l h. 
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form of whole cytosol or boiled cytosol yields a 
modest increase in DNA binding. The presence of 
both boiled cytosol and DTT yields more DNA 
binding than expected from an addition of the two 
effects; although the percent of total steroid-receptor 
complexes bound to DNA-cellulose is not as high as 
that in the original temperature-transformed cytosol 
before MMTS treatment. This observation suggested 
to us that the MMTS-derivatized receptor may have 
been separated from a beat-stable component of 
whole cytosol that promotes receptor binding to 
DNA. 
In the light of our previous results with Bio-Gel- 
separated receptors [11], we considered the possibility 
that thioredoxin might act like boiled cytosol to 
permit ,DNA binding. As thioredoxin is a thiol- 
containing, heat-stable protein of Mr 12,000, it would 
be inactivated by MMTS and separated from the 
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Fig. 1. Effect of a partially purified preparation of thio- 
redoxin (EAF) on DNA-cellulose binding activity of trans- 
formed receptors that have been treated with MMTS and 
passed through Sephadex G-50. Rat liver cytosol containing 
[3H]dexamethasone-bound transformed receptors was 
treated with 3.5 mM MMTS and filtered through Sephadex 
G-50 as described in the legend to Table 1. The Sephadex- 
filtered receptor preparation was divided into replicate 
aliquots which were incubated for 1 h on ice with 10ram 
DTI" in the presence of boiled cytosol (A), which was 
present at 40% of the final incubation volume, or with 
various amounts of the endogenous activating factor, EAF 
(O). The EAF was prepared from boiled rat liver cytosol by 
Sephadex chromatography as described under Experi- 
mental. In this experiment boiled cytosol and the EAF were 
preincubated at 25°C for 30rain with 10mM DTT and 
cooled to 4°C prior to addition to the Sephadex-filtered 
receptor preparation. Binding to DNA-cellulose is presented 
both as cpm/0.2 ml of undiluted cytosol and as the percent 
of total steroid-receptor complexes (assayed by charcoal 
assay) bound to DNA. The concentration of EAF is ex- 
pressed both as the number of microliters of EAF added to 
the incubation and as the final concentration of thioredoxin 
activity, which was assayed in the EAF preparation by 
insulin disulfide reduction method using purified rat liver 
thioredoxin as standard. 
played in the experiments of Table 1. Accordingly, in 
the experiment of Table 2 a preparation of partially 
purified rat liver thioredoxin or a preparation of 
highly purified thioredoxin was added back to 
MMTS-treated receptors that were passed through 
Sephadex G-50. The partially purified thioredoxin 
was originally called endogenous activating factor 
(EAF) on the basis of its ability to activate the 
oxidized glucocorticoid receptor to its steroid binding 
form [9] and we will refer to it here as EAF. As shown 
in Table 2, both EAF and rat liver thioredoxin 
purified to 80% of homogeneity were as effective as 
boiled cytosol in permitting Sephadex-separated, 
MMTS-treated, transformed receptors to bind to 
DNA in the presence of DTT. As shown in Fig. 1, the 
EAF preparation is maximally effective when it is 
present in the system at a concentration of about 1 
micromolar based on its thioredoxin activity as as- 
sayed by the insulin disulfide reduction method. The 
concentration of thioredoxin in the boiled rat liver 
cytosol is 3-4 micromolar [9] and its is being added 
to the Sephadex-separated receptor system at 40% of 
the assay volume, yielding a final concentration of 
1-1.5 micromolar thioredoxin. Thus, the EAF prepa- 
ration promotes receptor binding to DNA at concen- 
trations of thioredoxin activity that exist in rat liver 
cytosol. 
The stimulation of DNA binding by thioredoxin is not 
inhibited by thioredoxin antiserum 
If stimulation of DNA binding by Sephadex- 
separated, MMTS-treated receptors is specifically 
permitted by thioredoxin, then one might expect the 
effect to be blocked by thioredoxin antiserum. A 
rabbit antiserum against rat thioredoxin has been 
prepared, and as shown in Fig. 2, when the antiserum 
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Fig. 2. Effect of thioredoxin antiserum on the reduction of 
insulin by a reducing system composed of dithiothreitol and 
EAF. The rate of insulin reduction by EAF and DTT in the 
presence of buffer (1"7), preimmune control serum (O), or 
thioredoxin antiserum (0)  was determined as described 
under 'Experimental'. EAF was present at 7.5% of final 
incubation volume (45 #1 in a total assay volume of 600/~1). 
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Table 3. Failure of thioredoxin antiserum to affect reversal of MMTS inhibition by DTT 
and partially purified thioredoxin (EAF) 
% of total 
Binding to complexes bound to 
Condition DNA-cellulose DNA-cellulose 
cpm/0.2 ml 
MMTS-treated cytosol filtered 
through Sephadex G-50 
plus Buffer 2040 5 
plus DTT 1900 4 
plus EAF 3750 9 
plus DTT + EAF 9490 24 
plus DTT + EAF + preimmune serum 8720 24 
plus DTT + EAF + immune serum 9960 27 
Rat liver cytosol containing [3H]dexamethasone-bound, temperature-transformed receptors 
was incubated for 1 h with 3.5 mM MMTS and filtered through Sephadex G-50. 
Additions of DTT (10 mM, endogenous activating factor (EAF, 40% by volume), or 
EAF preincubated with preimmune or immune serum were made as indicated. The 
mixtures were incubated on ice for 1 h, and steroid binding and binding to DNA-cellulose 
were assayed. EAF was preincubated with 35% immune or preimmune serum at 25°C 
for 30 rain, DTT was added and the preincubation was continued for an additional hour 
on ice prior to adding the mixture to Sepbadex G-50 filtered cytosol. The concentration 
of antiserum in the final incubation mix containing the receptor was 17"/o by volume. 
disulf ide  r e d u c t i o n  a s say ,  t he re  is a n  i m m u n e - s p e c i f i c  
i nh ib i t i on  o f  the  p r o t e i n  r e d u c i n g  ac t iv i ty  o f  E A F .  A s  
s h o w n  in Tab l e  3, h o w e v e r ,  the  p re sence  o f  a h i gh  
c o n c e n t r a t i o n  o f  a n t i s e r u m  did  n o t  affect  s t i m u l a t i o n  
o f  r e cep to r  b i n d i n g  to  D N A  c a u s e d  by  the  c o m b i n a -  
t ion  o f  E A F  a n d  D T T .  A s  t he  s a m e  c o n c e n t r a t i o n  o f  
a n t i s e r u m  was  s h o w n  to  inh ib i t  t he  r e d u c i n g  f u n c t i o n  
o f  the  pa r t i a l ly  pur i f ied  t h i o r e d o x i n  in Fig.  2, it is 
c lear  t ha t  t he  r e d u c i n g  f u n c t i o n  o f  t h i o r e d o x i n  is n o t  
r equ i r ed  for  the  effect o n  r ecep t o r  b i n d i n g  to D N A .  
RNase  also stimulates D N A  binding 
G r a n d i c s  et al.[16] h a v e  r e p o r t e d  t h a t  ra t  l iver 
g l u c o c o r t i c o i d - r e c e p t o r  c o m p l e x e s  w h i c h  h a v e  been  
pur i f ied  a p p r o x  4000- fo ld  in the  u n t r a n s f o r m e d  f o r m  
by  aff ini ty c h r o m a t o g r a p h y  u n d e r g o  little c o n v e r s i o n  
to the  D N A - b i n d i n g  s ta te  w h e n  they  are  hea t ed ,  b u t  
D N A  b i n d i n g  can  be c o n f e r r e d  on  the  pur i f ied  c o m -  
p lexes  in a r e c o n s t i t u t e d  s y s t e m  in w h i c h  c rude  
cy toso l  h a s  been  added .  T h e  ac t ive  c o m p o n e n t  in ra t  
l iver cy toso l  was  f o u n d  to be a t ryps in - sens i t ive ,  
hea t - s t ab l e  (90°C for  30 min )  f ac to r  t h a t  is exc luded  
f r o m  S e p h a d e x  G - 2 5  [17]. T h e  fac to r  p r o m o t e s  D N A  
b i n d i n g  by pur i f ied  r ecep to r s  t ha t  h a v e  been  ther -  
m a l l y  t r a n s f o r m e d  a n d  it is ac t ive  a t  0°C.  T h i s  led 
S c h m i d t  et a/.[17] to p r o p o s e  t ha t  t r a n s f o r m a t i o n  is 
a " t w o - s t e p "  p rocess ,  wi th  the  first s tep  be ing  a 
t e m p e r a t u r e - m e d i a t e d  d i s soc i a t i on  o f  the  r ecep to r  
a n d  the  s e c o n d  be ing  a n  i n t e r ac t i on  o f  the  d i s soc i a t ed  
r ecep to r  wi th  a hea t - s t ab l e  c y t o p l a s m i c  p ro t e in  t h a t  
e n h a n c e s  its abi l i ty  to b ind  to D N A - c e l l u l o s e .  
S c h m i d t  et al.[18] h a v e  recent ly  s h o w n  tha t  R N a s e  
Table 4. Effect of RNase A, S-protein and S-peptide on receptor binding to DNA 
% of total 
Specific Binding to complexes bound 
Condition binding DNA-cellulose to DNA-cellulose 
cpm/0.2 ml 
Transformed cytosol alone 57,900 20,400 35 
plus MMTS 55,100 7340 13 
plus MMTS then DTT 58,000 13,400 23 
MMTS-treated cytosol filtered 
through Sepbadex G-50 
plus buffer alone 43,900 2450 6 
plus DTT 45,200 3730 8 
plus boiled cytosol 47,200 9210 20 
plus boiled cytosol and DTT 40,000 11,900 30 
plus EAF 51,900 9470 18 
plus EAF and DTT 46,000 10,600 23 
plus RNase 45,800 10,100 22 
plus RNase and DTT 44,100 12,300 28 
plus S-protein 46,600 5200 l 1 
plus S-protein and DTT 45,800 8000 17 
plus S-peptide 45,700 1770 4 
plus S-peptide and DTT 45.600 2810 6 
Rat liver cytosol containing temperature-transformed [3H]dexamethasone-bound receptors was 
incubated for 1 h on ice with 3.5 mM MMTS and filtered through Sephadex G.50. Additions 
of endogenous activating factor (EAF, 40% by volume, final protein concentration 
0.68 mg/ml), RNase A (0.68 mg/ml), an equimolar amount of RNase S-protein, or S-peptide, 
or each of these preincubated for I h at room temperature with 20 mM DTT were made as 
indicated, and the mixtures were incubated on ice for 1 h prior to assay of steroid binding 
and binding to DNA-cellulose. The concentration of DTT in the incubation with the receptor 
is 10 raM. MMTS-treated cytosol that was not filtered through Sephadex was reactivated by 
addition of DTr  after I h. 
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Table 5. Pretreatment of EAF, RNas¢ or S-protein with N-¢thylmaleimide does not affect their 
ability to promote receptor binding to DNA 
% of total 
Binding to complexes bound to 
Condition DNA-cellulos¢ DNA-cellulos¢ 
cpm/0.2 ml 
Transformed cytosol alone 13,700 31 
plus MMTS 7590 17 
Plus MMTS then DTT 14,400 33 
MMTS-treated eytosol filtered 
through Sephadex G-50 
plus buffer alone 4220 18 
plus DTT 5590 24 
plus NEM and D'IT 4210 18 
plus EAF 8100 34 
plus EAF and DTT 10,900 46 
plus NEM-treated EAF and DTT 9150 39 
plus RNase 9610 41 
plus RNase and DTT 12,200 51 
plus NEM-treated RNase and DTT 13,700 58 
plus S-protein 7670 32 
plus S-protein and DTT 11,100 47 
plus NEM-treated S-protein and DTT 12,700 54 
Sephadex-filtered, MMTS-treated, transformed steroid-receptor complexes were incubated for 
1 h on ice with the indicated additions and steroid binding and binding to DNA-cellulose 
were assayed as in previous experiments. For NEM-treatment, EAF (final concentration in 
assay 0.68mg protein/ml), RNase (final concentration 0.68mg/ml), and S-protein (at 
equimolar concentration to RNase) were preincubated at room temperature for 15 min with 
1 mM DTT, then 30 rain with 3 mM NEM, and then 10 mM DTT was added to inactivate 
unreacted NEM. NEM-treated or non-NEM-treated preparations were added to the 
Sephadex-filtered, MMTS-treated cytosol as indicated. 
A mimics the effect of  the endogenous heat- 
stable protein in permitting D N A  binding. RNase 
S-protein, a catalytically inactive fragment of 
RNase A that lacks a 20 amino acid segment (RNase 
S-peptide) at the amino terminal [19], was found to be 
as effective as intact RNase in their system. As shown 
in Table 4, both intact pancreatic RNase and RNase 
S-protein promote D N A  binding by Sephadex- 
separated, MMTS-treated, transformed receptors. 
An equimolar concentrat ion of the 20 amino acid 
S-peptide cleavage product does not  promote D N A  
binding. 
As the intact RNase (M, 13,700) and RNase 
S-protein (M, 11,200) are similar to thioredoxin in 
both size and heat stability, it is possible that both 
preparations could be contaminated with thio- 
redoxin. We have assayed both the RNase and the 
S-protein preparations by the insulin disulfide reduc- 
t ion method, however, and find no thioredoxin activ- 
ity, even when RNase is present in the assay at a 
concentration that is 10-fold higher than that em- 
ployed in the experiment of Table 4. As shown in 
Table 5, neither the activity of the RNase prepara- 
tions nor  the activity of the thioredoxin preparation 
in promoting D N A  binding is affected by treatment 
with N-ethylmaleimide. This again suggests that 
stimulation of receptor binding to D N A  is a 
nonspecific effect that is unrelated to the presence of 
thiol moieties in either the thioredoxin or RNase 
preparations. 
DISCUSSION 
Two laboratories have reported that a heat stable 
component  of rat liver cytosol promotes D N A  bind- 
ing by glucocorticoid receptors that were partially 
purified or extensively purified without being submit- 
ted initially to thermal transformation [11, 17]. As the 
effect of boiled cytosol in stimulating DNA binding 
can be replaced by partially purified or highly purified 
thioredoxin at concentrations that exist in the rat 
liver cytosol preparation (ref. 11, Table 2, Fig. 1), we 
have considered the possibility that thioredoxin 
might play a direct role in facilitating binding of the 
receptor to DNA.  In the case of phage T7 D N A  
polymerase, it has been shown that thioredoxin acts 
as an accessory protein that endows the polymerase 
with the ability to function on double-stranded nu- 
cleic acids[13]. Although modification of the 
SH-groups in thioredoxin by N-ethylmaleimide 
destroys its activity on the phage polymerase, no 
thiol-disulfide exchange appears to take place after 
thioredoxin binds to the enzyme [I 3]. It is tempting to 
consider that an analogous interaction might be 
occurring between the glucocorticoid receptor and 
thioredoxin to affect the D N A  binding activity of  the 
receptor. Several observations, however, argue 
against any biochemically meaningful interaction be- 
tween thioredoxin and the receptor: (1) the effect of  
partially purified thioredoxin in promoting D N A  
binding by MMTS-treated receptors in the presence 
of DTT is not  affected by antithioredoxin serum 
(Table 3); (2) RNase A and RNase S-protein produce 
a similar increase in binding (Table 4); (3) treatment 
with N-ethylmaleimide does not  affect the stimu- 
lation of D N A  binding caused by either the thio- 
redoxin or RNase preparations (Table 5). 
It seems rather clear that there is also no biochem- 
ically meaningful interaction between RNase and the 
glucocorticoid receptor in promoting D N A  binding. 
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This is inferred from the fact that the catalytically 
inactive RNase S-protein promotes D N A  binding by 
receptors, both in our system (Tables 4 and 5) and in 
the purified receptor system of  Schmidt et al.[18]. At 
least, it can be said that the effect of  the RNase 
preparation in our system is unrelated to the pre- 
sumed catalytic effects of  RNase on the size and 
DNA-binding activity of  glucocorticoid receptors 
that have been reported in rat liver cytosol and other 
systems [20, 21 ]. 
Neither our observations nor the more recent 
observations of  Schmidt et al.[18] support the " two 
step" model [17] of  transformation in which a dis- 
sociated receptor must associate with a heat-stable 
cytoplasmic peptide in order to bind to D N A -  
cellulose. It is entirely possible however that the 
receptor must associate with a metal in order to bind 
to DNA.  It is known from studies of  primary struc- 
ture that the D N A  binding domains of  glucocorticoid 
and other steroid receptors [22, 23] contain cysteine- 
rich motifs that by analogy with other proteins may 
constitute metal binding domains [24]. Similar motifs 
in the Xenopus transcription factor T F l l l A  are 
thought to bind zinc which is required for D N A  
binding by that protein [25]. It is possible that the 
presence of  such a trace metal could explain the 
effects of  boiled cytosol and the partially purified 
thioredoxin and RNase preparations on D N A  bind- 
ing observed in our experiments and in the experi- 
ments published by Schmidt et al.[17, 18]. Schmidt et 
al.[17] have inactivated the DNA-binding factor ac- 
tivity in liver cytosol by trypsin digestion. In contrast, 
we have not been able to affect the activity of  either 
boiled cytosol or the partially purified thioredoxin 
preparation by incubation with trypsin or chymo- 
trypsin. This argues against a heat-stable protein 
factor being required for D N A  binding and would be 
consistent with a metal effect. 
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